Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
PAR Technology $115 million convertible senior notes offering
The notes are due 2030
Central American Bank for Economic Integration $1.5 billion notes
The notes are due 2028
Emera exchange offer
We advised Emera on its exchange offer
Circle strategic commercial alliance with Binance to expand global USDC adoption
We advised Circle in entering into a unique strategic commercial arrangement with Binance to accelerate global USDC adoption
Norwegian Cruise Line $1.8 billion senior notes offering
The high-yield notes are due 2032
Banco Santander $2 billion notes offering
We advised Banco Santander on the offering
Banco Santander $3.5 billion cash tender offers
We advised Banco Santander on its tender offers for fixed-rate notes
Rakuten Group $550 million subordinated notes offering
The 8.125% reset notes are listed on the Singapore Exchange
JBS $1.75 billion senior notes offerings
The investment-grade notes are due 2035 and 2055